Skip to content

Study on the effectiveness of cyclophosphamide versus propofol in the induction of general anesthesia for upper abdominal surgery in elderly patients

Study on the effectiveness of cyclophosphamide versus propofol in the induction of general anesthesia for upper abdominal surgery in elderly patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061472
Enrollment
Unknown
Registered
2022-06-25
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Minhang Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=65 and =10 and =95% when breathing air; Systolic blood pressure (SBP) >=90mmHg and =60mmHg and =55 and <=100 beats/min; 8. No serious medical disease; 9. Be able to understand the research process and methods, and voluntarily participate in the research.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to general anesthesia or previous history of anesthesia accidents; 2. Known or suspected allergy or contraindication to propofol, cyclopofol excipients, benzodiazepines, opiates, muscle relaxants, etc.; 3. Patients complicated with craniocerebral loss, intracranial hypertension, stroke, unstable angina pectoris, myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, presence of a difficult airway, or determination of difficulty intubating the trachea (modified Markov score Level III or IV); 5. Uncontrolled diabetes or hypertension; 6. Severe liver dysfunction or severe renal insufficiency; 7. History of alcoholism or drug dependence; 8. Abuse or long-term use of narcotic, sedative and analgesic drugs; 9. Previous history of mental illness; 10. Participated in any drug clinical trials within 1 month prior to screening; 11. The reluctance of fertile women or men to use contraception throughout the trial period; Patients (including male subjects) who plan to become pregnant within 1 month after the trial; 12. Patients with any other factors deemed unsuitable for participation in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;

Countries

China

Contacts

Public ContactZhang Nu
zhangnu_1983@fudan.edu.cn+86 18930819046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026